To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Carlyle in $3.8bn vitamin take-private
The firm is paying a 57% premium over NYSE-listed NBTY’s recent average closing price.
